The arch-covered bridges in China's Zhejiang Province are cultural treasures of the world. Unfortunately, being constructed ...

Scientific discovery knows no geographical, communal, religious, ethnic, or political bias. It belongs universally and ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

Indian American physician-scientist and business executive Reshma Kewalramani, the CEO of Vertex Pharmaceuticals, has been ...

WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed its Annual Report on Form 10-K on April 15, 2025.

Born in Mumbai, Reshma moved to the United States in 1988. She pursued a career in medicine, earning her degree from Boston ...

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

Ultragenyx's strong revenue growth, diverse streams, and late-stage pipeline make it a standout in rare disease and gene ...

These shares could be just what the investment doctor ordered according to analysts. The post 3 of the best ASX 200 healthcare shares to bring your portfolio to life appeared first on The Motley Fool ...

Beam Therapeutics Inc.’s BEAM share price has surged by 5.12%, which has investors questioning if this is right time to sell.